Document is current
Any future updates will be listed below
-
Authors
Gasperetti, Tiziana
Welte, René
Oberacher, Herbert
Marx, Jana
Lorenz, Ingo
Schellongowski, Peter
Staudinger, Thomas
Burgmann, Karin
Eller, Philipp
Santner, Tobias
Griesmacher, Andrea
Pfisterer, Hartwig
Eschertzhuber, Stephan
Aigner, Maria
Joannidis, Michael
Bellmann, Romuald https://orcid.org/0000-0003-2861-3258
-
Funding
Funding for this research was provided by:
Austrian Science Fund (KLI 565-B3)
University of Innsbruck and Medical University of Innsbruck
- License Information
-
More Information
Article History
Received: 22 December 2020
Accepted: 8 March 2021
First Online: 20 April 2021
Declarations
:
: Peter Schellongowski reports personal fees from Astro-Pharma, Biotest, Novartis, KITE/Gilead, Shire, Pfizer and grants from Astro-Pharma outside the submitted work. Tobias Santner reports personal fees from Roche Diagnostics outside the submitted work. Romuald Bellmann reports personal fees from Merck Sharp & Dohme and Pfizer outside the submitted work.
: The study was approved by the local ethics committee (EudraCT no. 2013–005065-38). The study was carried out in accordance with the Declaration of Helsinki and Austrian law.
: Written informed consent was obtained from the patients.
: All authors read and approved the final manuscript.
: The datasets used and analysed during the current study are available from the corresponding author on request.
